Expect to See More HIV Meds Containing "Integrase Inhibitors"

Updated guidelines will lead to a shift in preferred meds for treating HIV in adults.

Expect more patients to start regimens with "integrase inhibitors"...especially bictegravir (Biktarvy) or dolutegravir (Tivicay, etc).

That's because integrase inhibitors are often better tolerated than other HIV meds...and generally have fewer drug interactions.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote